Indra Pamamull
First SEC filing: Feb. 8, 2022 · Latest: Feb. 8, 2022
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Feb. 4, 2022 | SKIN | A | 66,716 | · | · | 66,716 Direct | · | Acquired | (price as of 2026-10-05) |
| Sept. 10, 2021 | SKIN | A | 50,000 | · | · | 50,000 Direct | · | Acquired | (price as of 2026-10-05) |
| Aug. 12, 2021 | SKIN | A | 372,000 | · | · | 372,000 Direct | · | Acquired | (price as of 2026-10-05) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Sept. 10, 2021 | SKIN | Performance Restricted Stock Units | Class A Common Stock | · | · | 50,000 | Acquired |
| Aug. 12, 2021 | SKIN | Stock Options (right to buy) | Class A Common Stock | $20.63 | Aug. 12, 2031 | 372,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2022 | $181,268 | · | $1,256,474 | · | · | · | $571,974 | $2,009,716 |
| 2021 | $158,798 | · | $2,643,750 | $4,082,665 | $199,633 | · | · | $7,084,846 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.